Stay updated with breaking news from Chronic Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PROMISE II Trial Met Primary Endpoint Therapy Demonstrates 76% Limb Salvage in Patients with Chronic Limb-Threatening Ischemia Who Otherwise Faced Amputation LimFlow SA, a pioneer in the
FIRE1, today announced the close of a $25 million financing round led by new investors Andera Partners and Novo Holdings, with participation and ongoing support from existing investors Gilde Healthcare
System Designed to Reduce the Incidence of Positive Margins or Cancer Left Behind After Breast Cancer Surgery CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise
LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced
LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced